170 related articles for article (PubMed ID: 10744057)
1. Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma.
Mizuguchi M; Takashima S; Yamanouchi H; Nakazato Y; Mitani H; Hino O
J Neuropathol Exp Neurol; 2000 Mar; 59(3):188-96. PubMed ID: 10744057
[TBL] [Abstract][Full Text] [Related]
2. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
[TBL] [Abstract][Full Text] [Related]
3. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
[TBL] [Abstract][Full Text] [Related]
4. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis.
Mizuguchi M; Mori M; Nozaki Y; Momoi MY; Itoh M; Takashima S; Hino O
Acta Neuropathol; 2004 Jan; 107(1):47-52. PubMed ID: 14566415
[TBL] [Abstract][Full Text] [Related]
5. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.
Yeung RS; Katsetos CD; Klein-Szanto A
Am J Pathol; 1997 Nov; 151(5):1477-86. PubMed ID: 9358774
[TBL] [Abstract][Full Text] [Related]
6. TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer.
Hino O; Fukuda T; Satake N; Kobayashi T; Honda S; Orimoto K; Yamashita Y; Kikuchi Y
Prog Exp Tumor Res; 1999; 35():95-108. PubMed ID: 10377754
[No Abstract] [Full Text] [Related]
7. Tuberous sclerosis complex and DNA repair.
Habib SL
Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
[TBL] [Abstract][Full Text] [Related]
8. Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.
Tschuluun N; Wenzel HJ; Schwartzkroin PA
Epilepsy Res; 2007 Jan; 73(1):53-64. PubMed ID: 17011168
[TBL] [Abstract][Full Text] [Related]
9. Restoration of Normal Cerebral Oxygen Consumption with Rapamycin Treatment in a Rat Model of Autism-Tuberous Sclerosis.
Chi OZ; Wu CC; Liu X; Rah KH; Jacinto E; Weiss HR
Neuromolecular Med; 2015 Sep; 17(3):305-13. PubMed ID: 26048361
[TBL] [Abstract][Full Text] [Related]
10. Tuberous sclerosis: a syndrome of incomplete tumor suppression.
McCall T; Chin SS; Salzman KL; Fults DW
Neurosurg Focus; 2006 Jan; 20(1):E3. PubMed ID: 16459993
[TBL] [Abstract][Full Text] [Related]
11. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
[TBL] [Abstract][Full Text] [Related]
12. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of tuberous sclerosis.
Mizuguchi M; Takashima S
Brain Dev; 2001 Nov; 23(7):508-15. PubMed ID: 11701246
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
[TBL] [Abstract][Full Text] [Related]
15. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.
Nguyen-Vu PA; Fackler I; Rust A; DeClue JE; Sander CA; Volkenandt M; Flaig M; Yeung RS; Wienecke R
J Cutan Pathol; 2001 Oct; 28(9):470-5. PubMed ID: 11553313
[TBL] [Abstract][Full Text] [Related]
16. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
Yeung RS; Xiao GH; Jin F; Lee WC; Testa JR; Knudson AG
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11413-6. PubMed ID: 7972075
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma multiforme in a child with tuberous sclerosis complex.
Vignoli A; Lesma E; Alfano RM; Peron A; Scornavacca GF; Massimino M; Schiavello E; Ancona S; Cerati M; Bulfamante G; Gorio A; Canevini MP
Am J Med Genet A; 2015 Oct; 167A(10):2388-93. PubMed ID: 25946256
[TBL] [Abstract][Full Text] [Related]
18. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
[TBL] [Abstract][Full Text] [Related]
20. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]